Please assess the completion status of the following clinical trial:

Trial Title: Improving the Care of Diabetic Patients: A Randomized Trial of a Family Physician Office-Based Chronic Disease Care Model for Patients With Type 2 Diabetes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with type 2 diabetes (2003 classification by the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus) receiving any therapy with HbA1c of \> or = 7.0% between the ages of 40 - 75 years.~Exclusion Criteria:~* Type 1 diabetes~* Pregnancy~* Severe diabetic complications that include end stage renal disease requiring dialysis~* Proliferative retinopathy (growth of new vessels on the retina and posterior surface of the vitreous that requires laser therapy)~* Uncontrolled cardiovascular disease (CVS event within 1 year of enrollment)~* Psychiatric disease or cognitive impairment that would interfere with treatment compliance~* Cancer or terminally ill patients with less than 6 months life expectancy~* Blindness~* Other severe co- morbid diseases~* Participation in another intense multifactorial intervention for the management of type 2 diabetes~* Participation in another study

- Gender: ALL
- Minimum Age: 40 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Usual Care Group (Type: ACTIVE_COMPARATOR): The 'usual care' study arm (control) will reflect current patterns of care for patients with thpe 2 diabetes in the Capital Health region
- Enhanced Care Group (Type: EXPERIMENTAL): In the enhanced care group(intervention arm) the participants will receive a multifactorial intervention with three main components that include: optimized medical management, 2) support for development of enhanced patient self management skills, and 3) organized proactive follow-up by chronic disease management teams to support improvement in care.

Based on this trial design, predict the completion outcome and termination type (if applicable).